• Jayashree Dutta Department of Biotechnology, Gauhati University 781014
  • Mohan Chandra Kalita Department of Biotechnology, Gauhati University 781014


Objective: The antihyperglycaemic potentiality of Terminalia chebula leaves has not yet been investigated thoroughly compared to its fruit counterpart. Therefore, the purpose of this study was to assess the hypoglycaemic potentiality of Terminalia chebula Retz leaves both in vitro and in vivo.

Methods: Fresh leaves of T. chebula were collected, authenticated and grounded to a fine powder. The powdered material was extracted in methanol. The hypoglycaemic potentiality of the extract was accessed in vitro using enzyme alpha-amylase and alpha-glucosidase. The antihyperglycaemic activity of the methanol extract active fraction was accessed in vitro and in vivo. The active fraction thus obtained was partially characterized using Fourier transform infrared spectroscopy (FTIR) and High-performance liquid chromatography (HPLC) analysis.

Results: The crude leave methanol extract of Terminalia chebula demonstrated 100% α glucosidase inhibition with IC50–0.956±0.342 mg/ml compared to standard drug acarbose. Oral administration of the active fraction to diabetic rats loaded with maltose significantly (P<0.05) retarded the postprandial spike of blood glucose level compared to standard drug acarbose. Partial characterization of the fraction reveals the presence of hydrosoluble tannin gallic acid.

Conclusion: The study provides an in vitro and in vivo rationale evidence of Terminalia chebula leaves to retard postprandial hyperglycemia.

Keywords: Terminalia chebula, Postprandial hyperglycemia (PPHG), α amylase, α glucosidase, Active fraction (f5)


Download data is not yet available.

Author Biographies

Jayashree Dutta, Department of Biotechnology, Gauhati University 781014

Research Associate, Department of Biotechnology

Gauhati University

Mohan Chandra Kalita, Department of Biotechnology, Gauhati University 781014

Professor, Department of Biotechnology

Gauhati University


1. Satyanarayana U, Chakrapani A. Insulin, glucose, homeostasis and diabetes mellitus. Biochemistry. India (3rd edn): Elsevier; 2006. p. 680-1.
2. Stang J, Story M. Guidelines for Adolescent Nutrition Services; 2005. p. 167-82.
3. Guariguata L, Nolan T, Beagley J, Linnenkamp U, Jacqmain O. International Diabetic Federation Diabetes atlas, 6th edn; 2013.
4. Hurel SJ, Mohan V. Clinical decision making: managing postprandial hyperglycemia. J Assoc Physicians India 2006;54:871-6.
5. Yadav R, Tiwari P, Dhanaraj E. Risk factors and complications of type 2 diabetes in Asians. Curr Res Information Pharm Sci 2008;9 Suppl 2:8-12.
6. Gupta PC. Biological and pharmacological properties of Terminalia chebula Retz. (Haritaki)-an overview. Int J Pharm Pharm Sci 2012;4 Suppl 3:62-8.
7. Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 2002;81 Suppl 2:155-60.
8. Murali YK, Anand P, Tandon V, Singh R, Chandra R, Murthy PS. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes 2007;115 Suppl 10:641-6.
9. Rao NK, Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med 2006;6:17.
10. Bernfeld P. Amylases, a and b. Methods in Enzymology. New York (NY), London (UK): Academic Press; 1995;2:149-58.
11. Artanti N, Firmansyah T, Darmawan A. Bioactivities evaluation of indonesian mistletoes (Dendrophthoe pentandra (L.) Miq. leaves extracts. J Appl Pharm Sci 2012;2:24-7.
12. Singh U, Singh S, Kochhar A. Therapeutic potential of antidiabetic nutraceuticals. Phytopharmacology 2012;2 Suppl 1:144-69.
13. Hussain SA, Ahmed ZA, Mahwi TO, Aziz TA. Effect of quercetin on postprandial glucose excursion after mono-and disaccharides challenge in normal and diabetic rats. J Diabetes Mellitus 2012;2 Suppl1:82-7.
14. Dutta Jayashree, Kalita MC. In vitro hypoglycemic evaluation of seven culinary plants of North East India against type 2 diabetes. Asian J Pharm Clin Res 2016;9:209-12.
15. Jaiswal N, Srivastava SP, Bhatia V, Mishra A, Srivastava AK, Tamrakar AK, et al. Inhibition of alpha-glucosidase by Acacia nilotica prevents hyperglycemia along with the improvement of diabetic complication via aldose reductase inhibitors. J Diabetes Metab 2012;6:2-7.
16. Gao H, Huang YN, Gao B, Kawabata J. Chebulagic acid is a potent ? glucosidase inhibitor. Biosci Biotechnol Biochem 2008;72 Suppl 2:601-3.
17. Gholamhoseinian A, Fallah H, Sharifi F, Mirtajaddini M. The inhibitory effect of some iranian plants extracts on the alpha-glucosidase. Iran J Basic Med Sci 2008;11 Suppl 1:1-9.
18. Senthilkumar GP, Subramanian SP. Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats. J Appl Biomed 2008;6:105–15.
19. Huang YN, Zhao DD, Gao B, Zhong K, Zhu RX, Zhang Y, et al. Anti-hyperglycemic effect of chebulagic acid from the fruits of Terminalia chebula retz. Int J Mol Sci 2012;13 Suppl 5:6320-33.
20. Yin Z, Zhang W, Feng F, Zhang Y, Kang W. Alpha-glucosidase inhibitors isolated from medicinal plants. Food Sci Human Wellness 2014;3 Suppl 4:136-74.
21. Mahajan A, Pai N. Simultaneous isolation and identification of phytoconstituents from Terminalia chebula by preparative chromatography. J Chem Pharm Res 2010;2:97-103.
22. Klika KD, Ammar S, Jari S, Marja K, Jyrki L, Petri T, et al. The structural and conformational analyses and antioxidant activities of chebulinic acid and its thrice-hydrolyzed derivative, 2, 4-chebuloyl-?-D glucopyranoside, isolated from the fruit of Terminalia chebula. Arch Org Chem 2004;7:83-105.
23. Thinkratok A, Supkamonseni N, Srisawat R. Inhibitory potential of the Rambutan rind extract and tannin against alpha-amylase and alpha-glucosidase activities in vitro. International Conference on Food, Biological and Medical Sciences; 2014. p. 44-8.
24. Boath AS, Grussu D, Stewart DD, Mc Dougall GJ. Berry polyphenols inhibit digestive enzymes: a source of potential health benefits. Food Dig 2012;3:1–7.
25. Gangdhar M, Patil B, Yadav Sl, Datta S. Isolation and characterization of gallic acid from Terminalia Bellerica on carbohydrate regulatory enzymes system in vitro. Int J Res Ayurveda Pharm 2011;2 Suppl 2:559-62.
26. Coman C, Dumitri?a Rugina O, Socaciu C. Plants and natural compounds with antidiabetic action. Not Bot Horti Agrobo 2012;40 Suppl 1:314-25.
27. Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in the management of diabetes: a review. J Diabetes Metab Disord 2013;12 Suppl 1:43.
28. Govindappa MA. Review on the role of plant (s) extracts and its phytochemicals for the management of diabetes. Diabetes Metab 2015;6 Suppl 7:1-38.
29. Pandita NS, Vaidya AS. Therapeutic potential of plant phenolics for the management of diabetic retinopathy. Pharm Crops 2014;5 Suppl 1:29-38.
217 Views | 418 Downloads
How to Cite
Dutta, J., and M. C. Kalita. “ANTI HYPERGLYCEMIC EVALUATION OF TERMINALIA CHEBULA LEAVES”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 10, no. 11, Nov. 2018, pp. 43-48, doi:10.22159/ijpps.2018v10i11.28167.
Original Article(s)